Bangladesh has reported three additional dengue-related deaths, increasing the total fatalities for 2026 to 418, marking the third-highest annual toll since the country recorded its first dengue outbreak in 2000. This year’s figure follows 1,705 deaths in 2023 and 575 in 2024, according to data from the Directorate General of Health Services (DGHS).

A recent review by the Institute of Epidemiology, Disease Control and Research (IEDCR), led by director Quazi Ahmed Zaki, examined 119 dengue cases resulting in death. The study found that over one-third of patients died within 24 hours of hospital admission. Dengue shock syndrome was identified as the leading cause of death, accounting for 62.5 percent, followed by expanded dengue syndrome at 31.2 percent, dengue with bleeding at 16.1 percent, and other causes comprising 12.5 percent. The review also highlighted diagnostic delays of three days or more in many cases.

Zaki explained that hospital-based death review committees evaluate each fatality and report the findings to DGHS’s Disease Control unit. These assessments focus on causes of death, the quality of treatment provided, timing of diagnosis, patients’ health status prior to admission, and the use of contraindicated medications, aiming to identify gaps in patient care.

Public health expert Mushtuq Hussain attributed the rising death toll to shortcomings in healthcare policy, advocating for a shift from hospital-centered treatment toward community-based interventions. Hussain emphasized the importance of early diagnosis, appropriate patient management, and secondary-level observation, reserving tertiary hospitals and intensive care units for advanced treatment. He noted that financial pressures often compel low-income individuals to continue working despite fever symptoms, delaying diagnosis until serious complications emerge. Hussain recommended establishing a functional three-tier healthcare system and piloting free dengue testing at primary healthcare facilities, with referral protocols directing vulnerable patients to hospitals.

Meanwhile, associate professor HM Nazmul Ahsan of Shaheed Suhrawardy Medical College Hospital reported a surge in patients arriving in critical condition, many exhibiting dengue shock with undetectable blood pressure and falling oxygen saturation levels. Ahsan stressed that early treatment substantially improves recovery chances but delays in transportation, emergency evaluation, and admission can lead to irreversible organ damage and increased mortality risk. He observed an increase in severe complications this year—including liver, kidney, respiratory, and heart failure, as well as myocarditis—and suggested that the circulation of dengue virus serotype 3 (DENV-3) might be contributing to heightened disease severity, though further research is needed.

Medicine specialist ABM Abdullah pointed to repeat infections and delays in diagnosis and treatment as major factors behind the heightened death toll. He warned that individuals previously infected with dengue are more susceptible to severe complications upon reinfection and urged people experiencing fever and body aches to seek prompt medical advice and testing.

Prof Kabirul Bashar of Jahangirnagar University’s Department of Zoology forecasted that while the number of dengue deaths may not increase as rapidly as in October, fatalities are expected to persist through November with only a gradual decline. Bashar called for reinforced mosquito control measures, particularly targeting indoor environments where stagnant water provides breeding sites.